CISH and glioblastoma: Thus, the new YT–Vav1+CISH–/– and YT–Vav1+B2M–/– modified NK cell lines demonstrate greater cytotoxic activity against primary patient’s glioblastoma spheroids compared with the standard line, causing early metabolic rearrangements and evident decrease of tumor cells viability.